Li Jian, Zhao Yong, Mao Jinying
Department of Emergency, Neurology Division, Weifang People's Hospital, Weifang, Shangdong 261041, P.R. China.
The Second Department of Cardiology, Weifang People's Hospital, Weifang, Shangdong 261041, P.R. China.
Exp Ther Med. 2017 Mar;13(3):909-912. doi: 10.3892/etm.2017.4035. Epub 2017 Jan 11.
White matter (WM) injury following acute ischemic stroke (AIS) is associated with cognitive decline. Establishing relationships between the specific cognitive tests used to assess post-AIS cognition and various clinical indices of WM injury severity and distribution may aid in prognosis and early treatment decisions. We enrolled 62 patients with AIS to Weifang People's Hospital between September 2014 and August 2015. WM lesion severity and distribution were examined by computed tomography (CT) and magnetic resonance imaging (MRI). The Blennow scale was used for scoring the distribution and degree of WM lesions (WMLs) on CT images, the Fazekas scale for scoring periventricular and deep WMLs on MRI, and the Cholinergic Pathways Hyperintensities Scale (CHIPS) for scoring MRI manifestation of cholinergic fiber damage. The 8-domain Montreal Cognitive Assessment (MoCA) was used to evaluate cognitive function. Mean ± standard deviation scores on the Blennow scale was 1.6±0.5; Fazekas scale, 3.4±0.8; and CHIPS, 65.7±12.5. The proportion of patients with a MoCA score <26 (indicating cognitive dysfunction) was significantly higher in subgroups with Blennow scale score >2, Fazekas scale score >4, and CHIPS score >51 (all P<0.001). The MoCA score was negatively correlated with Blennow scale score (r=-0.326, P=0.002), Fazekas scale score (r=-0.404, P=0.031), and CHIPS score (r=-0.234, P=0.042). Thus, the degree and distribution of whole-brain, deep, and cholinergic WMLs were associated with cognitive impairment. The Blennow scale, Fazekas scale, and CHIPS all provide good predictive efficacy of post-AIS cognitive dysfunction.
急性缺血性卒中(AIS)后的白质(WM)损伤与认知功能下降有关。建立用于评估AIS后认知功能的特定认知测试与WM损伤严重程度和分布的各种临床指标之间的关系,可能有助于预后判断和早期治疗决策。2014年9月至2015年8月期间,我们将62例AIS患者纳入潍坊市人民医院。通过计算机断层扫描(CT)和磁共振成像(MRI)检查WM病变的严重程度和分布。使用布莱诺量表对CT图像上WM病变(WMLs)的分布和程度进行评分,使用法泽卡斯量表对MRI上脑室周围和深部WMLs进行评分,使用胆碱能通路高信号量表(CHIPS)对胆碱能纤维损伤的MRI表现进行评分。采用8个领域的蒙特利尔认知评估量表(MoCA)评估认知功能。布莱诺量表的平均±标准差评分为1.6±0.5;法泽卡斯量表为3.4±0.8;CHIPS量表为65.7±12.5。在布莱诺量表评分>2、法泽卡斯量表评分>4和CHIPS量表评分>51的亚组中,MoCA评分<26(表明存在认知功能障碍)的患者比例显著更高(均P<0.001)。MoCA评分与布莱诺量表评分(r=-0.326,P=0.002)、法泽卡斯量表评分(r=-0.404,P=0.031)和CHIPS量表评分(r=-0.234,P=0.042)呈负相关。因此,全脑、深部和胆碱能WMLs的程度和分布与认知障碍有关。布莱诺量表、法泽卡斯量表和CHIPS量表均对AIS后认知功能障碍具有良好的预测效能。